310 related articles for article (PubMed ID: 27242795)
21. Innate lymphoid cells in normal and disease: An introductory overview.
Moretta L; Locatelli F
Immunol Lett; 2016 Nov; 179():1. PubMed ID: 27400678
[TBL] [Abstract][Full Text] [Related]
22. Transient Expression of GATA3 in Hematopoietic Stem Cells Facilitates Helper Innate Lymphoid Cell Differentiation.
Tufa DM; Yingst AM; Shank T; Shim S; Trahan GD; Lake J; Woods R; Jones KL; Verneris MR
Front Immunol; 2019; 10():510. PubMed ID: 30949172
[TBL] [Abstract][Full Text] [Related]
23. The Development and Diversity of ILCs, NK Cells and Their Relevance in Health and Diseases.
Zhang Y; Huang B
Adv Exp Med Biol; 2017; 1024():225-244. PubMed ID: 28921473
[TBL] [Abstract][Full Text] [Related]
24. Novel treatment of severe combined immunodeficiency utilizing ex-vivo T-cell depleted haploidentical hematopoietic stem cell transplantation and CD45RA+ depleted donor lymphocyte infusions.
Brodszki N; Turkiewicz D; Toporski J; Truedsson L; Dykes J
Orphanet J Rare Dis; 2016 Jan; 11():5. PubMed ID: 26768987
[TBL] [Abstract][Full Text] [Related]
25. Reconstitution of lymphocyte subpopulations after hematopoietic stem cell transplantation: comparison of hematologic malignancies and donor types in event-free patients.
Park BG; Park CJ; Jang S; Chi HS; Kim DY; Lee JH; Lee JH; Lee KH
Leuk Res; 2015 Dec; 39(12):1334-41. PubMed ID: 26422556
[TBL] [Abstract][Full Text] [Related]
26. Source of hematopoietic progenitor cells determines their capacity to generate innate lymphoid cells ex vivo.
Omar SZ; van Hoeven V; Haverkate NJE; Van der Meer JMR; Voermans C; Blom B; Hazenberg MD
Cytotherapy; 2024 Apr; 26(4):334-339. PubMed ID: 38363249
[TBL] [Abstract][Full Text] [Related]
27. Haploidentical hemopoietic stem cell transplantation for the treatment of high-risk leukemias: how NK cells make the difference.
Locatelli F; Pende D; Maccario R; Mingari MC; Moretta A; Moretta L
Clin Immunol; 2009 Nov; 133(2):171-8. PubMed ID: 19481979
[TBL] [Abstract][Full Text] [Related]
28. Negative depletion of α/β+ T cells and of CD19+ B lymphocytes: a novel frontier to optimize the effect of innate immunity in HLA-mismatched hematopoietic stem cell transplantation.
Locatelli F; Bauquet A; Palumbo G; Moretta F; Bertaina A
Immunol Lett; 2013; 155(1-2):21-3. PubMed ID: 24091162
[TBL] [Abstract][Full Text] [Related]
29. Helper Innate Lymphoid Cells in Allogenic Hematopoietic Stem Cell Transplantation and Graft Versus Host Disease.
Quatrini L; Tumino N; Moretta F; Besi F; Vacca P; Moretta L
Front Immunol; 2020; 11():582098. PubMed ID: 33101308
[TBL] [Abstract][Full Text] [Related]
30. Beyond NK cells: the expanding universe of innate lymphoid cells.
Cella M; Miller H; Song C
Front Immunol; 2014; 5():282. PubMed ID: 24982658
[TBL] [Abstract][Full Text] [Related]
31. Activated innate lymphoid cells are associated with a reduced susceptibility to graft-versus-host disease.
Munneke JM; Björklund AT; Mjösberg JM; Garming-Legert K; Bernink JH; Blom B; Huisman C; van Oers MH; Spits H; Malmberg KJ; Hazenberg MD
Blood; 2014 Jul; 124(5):812-21. PubMed ID: 24855210
[TBL] [Abstract][Full Text] [Related]
32. Group 3 innate lymphoid cells (ILC3s): Origin, differentiation, and plasticity in humans and mice.
Montaldo E; Juelke K; Romagnani C
Eur J Immunol; 2015 Aug; 45(8):2171-82. PubMed ID: 26031799
[TBL] [Abstract][Full Text] [Related]
33. Identification of aceNKPs, a committed common progenitor population of the ILC1 and NK cell continuum.
Rodriguez-Rodriguez N; Clark PA; Gogoi M; Ferreira ACF; Kerscher B; Crisp A; Jolin HE; Murphy JE; Sivasubramaniam M; Pedro L; Walker JA; Heycock MWD; Shields JD; Barlow JL; McKenzie ANJ
Proc Natl Acad Sci U S A; 2022 Dec; 119(49):e2203454119. PubMed ID: 36442116
[TBL] [Abstract][Full Text] [Related]
34. Maintenance of Immune Homeostasis through ILC/T Cell Interactions.
von Burg N; Turchinovich G; Finke D
Front Immunol; 2015; 6():416. PubMed ID: 26322047
[TBL] [Abstract][Full Text] [Related]
35. Involvement of mature donor T cells in the NK cell reconstitution after haploidentical hematopoietic stem-cell transplantation.
Nguyen S; Kuentz M; Vernant JP; Dhedin N; Bories D; Debré P; Vieillard V
Leukemia; 2008 Feb; 22(2):344-52. PubMed ID: 18033316
[TBL] [Abstract][Full Text] [Related]
36. Unique Eomes(+) NK Cell Subsets Are Present in Uterus and Decidua During Early Pregnancy.
Montaldo E; Vacca P; Chiossone L; Croxatto D; Loiacono F; Martini S; Ferrero S; Walzer T; Moretta L; Mingari MC
Front Immunol; 2015; 6():646. PubMed ID: 27004067
[TBL] [Abstract][Full Text] [Related]
37. Tolerance induction between two different strains of parental mice prevents graft-versus-host disease in haploidentical hematopoietic stem cell transplantation to F1 mice.
Guo Y; Zhang L; Wan S; Sun X; Wu Y; Yu XZ; Xia CQ
Biochem Biophys Res Commun; 2014 Apr; 446(4):1035-41. PubMed ID: 24661874
[TBL] [Abstract][Full Text] [Related]
38. Natural killer cells in the treatment of high-risk acute leukaemia.
Locatelli F; Moretta F; Brescia L; Merli P
Semin Immunol; 2014 Apr; 26(2):173-9. PubMed ID: 24613727
[TBL] [Abstract][Full Text] [Related]
39. Facilitating T-cell immune reconstitution after haploidentical transplantation in adults.
Waller EK; Giver CR; Rosenthal H; Somani J; Langston AA; Lonial S; Roback JD; Li JM; Hossain MS; Redei I
Blood Cells Mol Dis; 2004; 33(3):233-7. PubMed ID: 15528137
[TBL] [Abstract][Full Text] [Related]
40. Role of alloreactive KIR2DS1(+) NK cells in haploidentical hematopoietic stem cell transplantation.
Marcenaro E; Carlomagno S; Pesce S; Della Chiesa M; Moretta A; Sivori S
J Leukoc Biol; 2011 Oct; 90(4):661-7. PubMed ID: 21791599
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
